Central Nervous System Toxicity After Botulinum Neurotoxin Injection

Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilkhchoui, Yashar, Ghaly, Ramsis F., Knezevic, N. Nick, Candido, Kenneth D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821148/
https://www.ncbi.nlm.nih.gov/pubmed/24223367
http://dx.doi.org/10.5812/aapm.9356
Descripción
Sumario:Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinson’s disease who received BoNT injections to treat painful spasticity in her hands. She developed severe generalized dystonia shortly after BoNT injections.

Ejemplares similares